Jeff Lewis, director of Edinburgh based IFA RobMac summarises the impact that the news of an imminent vaccine immunisation program on investment markets.
“Here’s a short market summary of where we are at with the vaccines and its effect on investment market sentiment.
Brexit negotiations remain tense, but financial markets remain more interested in the vaccine.
UK is rolling out the Pfizer vaccine today with the US likely to approve Pfizer this week and Moderna next week with hope that the Oxford/Astra Zeneca will follow in the UK.
The big unknown around the vaccine is the degree to which it would reduce transmission.
Investment Analysts’ New Year outlooks are beginning to arrive – and exhibiting a pro-risk bias which will be positive for continuing market growth and returns on portfolios.
We expect the risk-on rally to continue this festive season and into the new year as we emerge from this latest lockdown.
This positive news really means that clients should have confidence to remain invested even if there is still uncertainty in the air.”
If you are interested in learning about what makes RobMac different and think that we can help, then please get in touch. If you would like to discuss your financial position or mortgage further, you can arrange to meet either face to face or online with one of our financial advisers by scheduling a meeting here >>
Robson Macintosh & Company Ltd.
15 Manor Place, Edinburgh, Scotland, EH3 7DH
Tel: 0131 226 6700 Email: email@example.com
Registered in Scotland No. - SC232903.
Registered office: 15 Manor Place, Edinburgh, EH3 7DH
This function has been disabled for Robson Macintosh.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.